Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.
Malignant mesothelioma (MM) is a fatal disease in dire need of therapy. The role of inflammasomes in cancer is not very well studied, however, literature supports both pro-and anti-tumorigenic effects of inflammasomes on cancer depending upon the type of cancer. Asbestos is a causative agent for MM...
Main Authors: | Catherine Westbom, Joyce K Thompson, Alan Leggett, Maximilian MacPherson, Stacie Beuschel, Harvey Pass, Pamela Vacek, Arti Shukla |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4687055?pdf=render |
Similar Items
-
Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin
by: Carbone Michele, et al.
Published: (2010-12-01) -
Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.
by: Kheng Newick, et al.
Published: (2012-01-01) -
Impact of relatively new chemotherapeutic agents on the outcome of Egyptian patients with advanced malignant pleural mesothelioma
by: Gaafar R, et al.
Published: (2014-08-01) -
Malignant Mesothelioma
by: Daniel L. Pouliquen, et al.
Published: (2021-07-01) -
Malignant Mesothelioma
by: Phunchai Charuscharoenwitthaya, et al.
Published: (2002-09-01)